Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
64.4M
-
Shares change
-
-686K
-
Total reported value, excl. options
-
$4.05B
-
Value change
-
-$117M
-
Put/Call ratio
-
1.68
-
Number of buys
-
100
-
Number of sells
-
-103
-
Price
-
$62.85
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q4 2021
252 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q4 2021.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.4M shares
of 1.09B outstanding shares and own 5.9% of the company stock.
Largest 10 shareholders include Invesco Ltd. (7.25M shares), BAILLIE GIFFORD & CO (5.14M shares), Capital World Investors (4.08M shares), BlackRock Inc. (3.69M shares), WELLINGTON MANAGEMENT GROUP LLP (3.55M shares), BRILLIANCE ASSET MANAGEMENT LTD (3.32M shares), FMR LLC (3.07M shares), VIKING GLOBAL INVESTORS LP (3.02M shares), CREDIT SUISSE AG/ (2.93M shares), and VANGUARD GROUP INC (2.2M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.